Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jian L Campian"'
Autor:
Kyungwha Lee, Jeeyun Lee, Mahesh Seetharam, Jae Lyun Lee, Jung-Yun Lee, Byoung Chul Cho, Myoung Ho Jang, Yujie Zhao, Nari Yun, Alex A Adjei, Chong Woo Park, Jian L Campian, Wen Wee Ma, Dongwoo Chae, Woosun Lee, Wooyul Lee, Sosun Park, Bochan Seo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/bade833e049342d5b94d87b5f5d30fab
Autor:
Mason J Webb, William G Breen, Nadia N Laack, Konstantinos Leventakos, Jian L Campian, Ugur Sener
Publikováno v:
CNS Oncology, Vol 12, Iss 3 (2023)
Leptomeningeal disease (LMD) remains a challenging condition with a dismal prognosis. In this case study, we report partial response of LMD in a patient with metastatic large cell neuroendocrine carcinoma following treatment with proton craniospinal
Externí odkaz:
https://doaj.org/article/d3b7047a102c45deb04e6372c3d0e4c3
Autor:
Eric C Leuthardt, Chong Duan, Michael J Kim, Jian L Campian, Albert H Kim, Michelle M Miller-Thomas, Joshua S Shimony, David D Tran
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148613 (2016)
BACKGROUND:Poor central nervous system penetration of cytotoxic drugs due to the blood brain barrier (BBB) is a major limiting factor in the treatment of brain tumors. Most recurrent glioblastomas (GBM) occur within the peritumoral region. In this st
Externí odkaz:
https://doaj.org/article/f0e2e16082c94d5582edd75b7313f69c
Autor:
Jing Xi, Bilal Hassan, Ruth G. N. Katumba, Karam Khaddour, Akshay Govindan, Jingqin Luo, Jiayi Huang, Jian L. Campian
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Differentiating true glioblastoma multiforme (GBM) from pseudoprogression (PsP) remains a challenge with current standard magnetic resonance imaging (MRI). The objective of this study was to explore whether patients’ absolute ly
Externí odkaz:
https://doaj.org/article/53af5ed2448844a5843302f96b921ac7
Autor:
Luciano Galdieri, Arijita Jash, Olga Malkova, Diane D. Mao, Patrick DeSouza, Yunli E. Chu, Amber Salter, Jian L. Campian, Kristen M. Naegle, Cameron W. Brennan, Hiroaki Wakimoto, Stephen T. Oh, Albert H. Kim, Milan G. Chheda
Publikováno v:
JCI Insight, Vol 6, Iss 4 (2021)
Most patients with glioblastoma (GBM) die within 2 years. A major therapeutic goal is to target GBM stem cells (GSCs), a subpopulation of cells that contribute to treatment resistance and recurrence. Since their discovery in 2003, GSCs have been isol
Externí odkaz:
https://doaj.org/article/3ad4223883d44065a3189bf98ee59bd8
Autor:
Tanner M. Johanns, Christopher A. Miller, Connor J. Liu, Richard J. Perrin, Diane Bender, Dale K. Kobayashi, Jian L. Campian, Michael R. Chicoine, Ralph G. Dacey, Jiayi Huang, Edward F. Fritsch, William E. Gillanders, Maxim N. Artyomov, Elaine R. Mardis, Robert D. Schreiber, Gavin P. Dunn
Publikováno v:
OncoImmunology, Vol 8, Iss 4 (2019)
Neoantigens represent promising targets for personalized cancer vaccine strategies. However, the feasibility of this approach in lower mutational burden tumors like glioblastoma (GBM) remains unknown. We have previously reported the use of an immunog
Externí odkaz:
https://doaj.org/article/8dde9e453942466c919f33fd089ee9d6
Autor:
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, William J Laxen, Amanda Munoz-Casabella, Matthew D Hoplin, Samar Ikram, Abdullah Bin Zubair, Katherine M Andersen, Arthur E Warrington, Paul A Decker, Timothy J Kaufmann, Jian L Campian, Jeanette E Eckel-Passow, Sani H Kizilbash, Silvia Tortorelli, Terry C Burns
Publikováno v:
medRxiv
D-2-hydroxyglutarate (D-2-HG) is a well-established oncometabolite of isocitrate dehydrogenase (IDH) mutant gliomas. While prior studies have demonstrated that D-2-HG is elevated in the cerebrospinal fluid (CSF) of patients with IDH-mutant gliomas1,2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fe7c909c14104cb0444e6d8a2ca282f
https://doi.org/10.1093/noajnl/vdad061
https://doi.org/10.1093/noajnl/vdad061
Autor:
Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Michael J Fisher, Rakesh K Jain, James Tonsgard, Nicole J Ullrich, Coretta Thomas, Lloyd J Edwards, Bruce Korf, Roger Packer, Matthias A Karajannis, Jaishri O Blakeley
Publikováno v:
Neuro-Oncology.
Background Prospective data on maintenance therapy with bevacizumab for persons with NF2-related schwannomatosis (NF2-SWN) is lacking. In this prospective multicenter phase II study, we evaluated the efficacy, safety, and tolerability of bevacizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c5527b34ea3aea5d61a5458de546553
https://doi.org/10.1093/neuonc/noad066
https://doi.org/10.1093/neuonc/noad066
Autor:
Sheng-Kwei Song, Albert H. Kim, Sonika Dahiya, Jr-Shin Li, Jian L. Campian, Michael Wallendorf, Diane D. Mao, Sam E. Gary, Ruimeng Yang, Chunyu Song, Rowland H. Han, Liang Wang, Anthony T. Wu, Peng Sun, Qingsong Yang, Joshua Lin, Xiran Liu, Richard L. Price, Zezhong Ye
Supplementary methods, figures and tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33c9c04cd2b7dc9d55bcc6da2f7c324
https://doi.org/10.1158/1078-0432.22476903
https://doi.org/10.1158/1078-0432.22476903
Autor:
Sheng-Kwei Song, Albert H. Kim, Sonika Dahiya, Jr-Shin Li, Jian L. Campian, Michael Wallendorf, Diane D. Mao, Sam E. Gary, Ruimeng Yang, Chunyu Song, Rowland H. Han, Liang Wang, Anthony T. Wu, Peng Sun, Qingsong Yang, Joshua Lin, Xiran Liu, Richard L. Price, Zezhong Ye
Purpose:Glioblastoma (GBM) is one of the deadliest cancers with no cure. While conventional MRI has been widely adopted to examine GBM clinically, accurate neuroimaging assessment of tumor histopathology for improved diagnosis, surgical planning, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8a443832f316bdfb2a34f1e5fa3371
https://doi.org/10.1158/1078-0432.c.6529518
https://doi.org/10.1158/1078-0432.c.6529518